Govt disburses Rs 36,754 cr under PLI schemes
As of June 30, 2026, the Indian government has disbursed a total of Rs 36,754 crore under the Production Linked Incentive (PLI) schemes, according to the Commerce and Industry Ministry. The PLI program, launched in 2020, aimed to boost India's manufacturing sector, attract investments, promote exports, create jobs, and reduce import reliance. The scheme covers 14 key sectors with an approved budget of Rs 1.91 lakh crore.
By June 30, 2026, the PLI schemes had attracted actual investments of Rs 2.58 lakh crore, resulting in production and sales worth Rs 23.79 lakh crore and exports of Rs 15.53 lakh crore. This has led to the generation of over 14.57 lakh direct and indirect jobs, along with cumulative incentives amounting to Rs 36,754 crore.
The pharmaceutical sector has seen significant success under the PLI scheme, with cumulative sales exceeding Rs 3.64 lakh crore. The program has enabled the domestic manufacture of 1,931 pharmaceutical products, including 191 bulk drugs produced in India for the first time. Major global players like Siemens, Wipro GE, and Philips have participated in technology-transfer projects, facilitating the domestic production of advanced medical equipment such as CT/MRI systems, cath labs, and ultrasonography devices.
PLI beneficiaries have achieved significant domestic sales of Rs 6,475 crore, with exports totaling Rs 560 crore and revenue from implants amounting to Rs 1,400 crore. The government has also launched an online platform for Indian companies to generate sponsorship letters for foreign professionals to participate in production-related activities under the e-Production Investment Business Visa (e-B-4 Visa) in November 2025.
This digital system aims to streamline the process, reduce paperwork, and improve ease of doing business in India.
Written by urgent.news from The Economic Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
